| Market Cap | ₹9,408Cr |
| ROE | 77.82% |
| P/E Ratio(TTM) | 43.18 |
| EPS(TTM) | 94.61 |
| P/B Ratio | 36.60 |
| Dividend Yield | 1.34% |
| Industry P/E | 38.34 |
| Book Value | 111.60 |
| Debt to Equity | 0.11 |
| Face Value | 10 |
| Managing Director | Himanshu Bakshi |
| Founded | 2023 |
| NSE Symbol | SANOFICONR |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 38.87 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 40.33 | ||
| Pfizer | NA (0.00%) | 25.12 | ||
| Astrazeneca Pharma India | NA (0.00%) | 103.59 |